Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

After a year of dwindling coffers and repeated layoff rounds, the Southern California biotech firm Viracta Therapeutics has ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...

It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.